Kiarash Tanha

In 2022, I joined the Oxford Vaccine Group after four years of conducting collaborative research projects and applying statistical analyses in RCTs and observational studies.

Currently, I help design, set up, analyse and disseminate various vaccine trials, including COV-Boost, PERISCOPE, SALVO, RESPECCT, and RATIONALE.

I was awarded an NIHR pre-doctoral fellowship in 2023, where I investigated the application of novel designs in controlled human infection model (CHIM) vaccine trials, utilising historical data.

My research interests primarily focus on developing efficient trial designs, particularly in enhancing the efficiency of controlled human infection models (CHIMs) for vaccine development. My primary focus is on utilising Bayesian design in vaccine CHIMs, incorporating historical data to reduce sample size.